Professor Rick Rylance: What starts in the tea room can end in the boardroom'

Research councils UK Champion for research careers

Cameron appoints new business advice council

David Cameron will today announce the membership of a new business advisory group that is set to meet quarterly to provide what Downing Street will describe as "high-level advice on critical business and economic issues facing the country". Its membership is made up of 17 leading businessmen, and two women.

GSK's Avandia banned in Europe on heart worries

Glaxosmithkline was dealt a blow last night when European regulators recommended that its blockbuster diabetes drug, Avandia, should be withdrawn from sale amid fears that the treatment could pose serious health risks.

Goldmans M&A expert to join GSK

Glaxosmithkline has appointed Goldman Sachs' leading European mergers and acquisition (M&A) banker, Simon Dingemans, as its finance director.

Genzyme hopes for higher bid from Sanofi-Aventis

Genzyme, the pioneering US biotechnology company whose drugs are among the most expensive in the world, is plotting tactics to extract as much money as possible for its shareholders in a takeover by the French pharmaceutical giant Sanofi-Aventis.

AstraZeneca's triple whammy of good news pleases market

AstraZeneca pleased the market with a triple dose of good news yesterday as it won endorsement in the United States for its new blood-thinning drug Brilinta, reported strong results and doubled its share buyback programme.

Lucozade and Irn-Bru to carry hyperactivity warnings

The makers of two of Britain's best-selling soft drinks, Lucozade and Irn-Bru, have been forced to warn parents that the drinks may cause hyperactivity. A newly introduced EU law compels both drinks to display a warning that they contain artificial colours linked to behavioural problems in young children.

Investment Column: Glaxo looks cheap as it turns back to basics

Hochschild Mining; Euromoney

David Prosser: Another twist to come at SSL?

Outlook Farewell, then, SSL International, the condom-to-footwear combine now being lined up for a sale. Nevertheless, investors should not assume – as many in the market seemed to yesterday – that Reckitt Benckiser's offer for the business is absolutely the last word on the sale process. While SSL recommends the Reckitt offer, other bidders may yet emerge.

Glaxo sets aside £1.6bn for outstanding lawsuits

The drugs giant GlaxoSmithKline disclosed yesterday that it has set aside a record £1.57bn to meet legal charges during the second quarter. The money will be ringfenced to end a number of legal wrangles, including most of the claims involving its diabetes treatment Avandia.

US regulator's panel declares Glaxo diabetes drug is safe

Glaxosmithkline's diabetes drug Avandia is safe enough to stay on the market, a panel of 33 medical experts decided last night at the conclusion of a contentious two-day hearing.

Swine flu plan cost £1.2bn but report praises response

Dealing with the swine flu outbreak that did not become the pandemic people had feared cost £1.2bn.

Stephen Foley: The best prescription for pharma firms

US Outlook: It was a legal battering in the US over the depression medicine Paxil that bounced GlaxoSmithKline into setting up an online register of all its clinical trial data, regardless of whether it had pushed to have the results of a study published in a medical journal. The company had been accused of burying studies which showed the medicine was less effective or more dangerous.

Breast cancer victims to be denied life-extending drug

Up to 2,000 women with advanced breast cancer will not be given access on the NHS to a drug that could extend their lives, it was announced yesterday.

Career Services

Day In a Page

Independent Travel
Pompeii, Capri & the Bay of Naples
Seven Cities of Italy
Burgundy, the River Rhone & Provence
Prague, Budapest and Vienna
Lake Garda
3.	Provence 6 nights B&B by train from £599pp
Prices correct as of 20 February 2015
Homeless Veterans campaign: Donations hit record-breaking £1m target after £300,000 gift from Lloyds Bank

Homeless Veterans campaign

Donations hit record-breaking £1m target after huge gift from Lloyds Bank
Flight MH370 a year on: Lost without a trace – but the search goes on

Lost without a trace

But, a year on, the search continues for Flight MH370
Germany's spymasters left red-faced after thieves break into brand new secret service HQ and steal taps

Germany's spy HQ springs a leak

Thieves break into new €1.5bn complex... to steal taps
International Women's Day 2015: Celebrating the whirlwind wit of Simone de Beauvoir

Whirlwind wit of Simone de Beauvoir

Simone de Beauvoir's seminal feminist polemic, 'The Second Sex', has been published in short-form for International Women's Day
Mark Zuckerberg’s hiring policy might suit him – but it wouldn’t work for me

Mark Zuckerberg’s hiring policy might suit him – but it wouldn’t work for me

Why would I want to employ someone I’d be happy to have as my boss, asks Simon Kelner
Confessions of a planespotter: With three Britons under arrest in the UAE, the perils have never been more apparent

Confessions of a planespotter

With three Britons under arrest in the UAE, the perils have never been more apparent. Sam Masters explains the appeal
Russia's gulag museum 'makes no mention' of Stalin's atrocities

Russia's gulag museum

Ministry of Culture-run site 'makes no mention' of Stalin's atrocities
The big fresh food con: Alarming truth behind the chocolate muffin that won't decay

The big fresh food con

Joanna Blythman reveals the alarming truth behind the chocolate muffin that won't decay
Virginia Ironside was my landlady: What is it like to live with an agony aunt on call 24/7?

Virginia Ironside was my landlady

Tim Willis reveals what it's like to live with an agony aunt on call 24/7
Paris Fashion Week 2015: The wit and wisdom of Manish Arora's exercise in high camp

Paris Fashion Week 2015

The wit and wisdom of Manish Arora's exercise in high camp
8 best workout DVDs

8 best workout DVDs

If your 'New Year new you' regime hasn’t lasted beyond February, why not try working out from home?
Paul Scholes column: I don't believe Jonny Evans was spitting at Papiss Cissé. It was a reflex. But what the Newcastle striker did next was horrible

Paul Scholes column

I don't believe Evans was spitting at Cissé. It was a reflex. But what the Newcastle striker did next was horrible
Miguel Layun interview: From the Azteca to Vicarage Road with a million followers

From the Azteca to Vicarage Road with a million followers

Miguel Layun is a star in Mexico where he was criticised for leaving to join Watford. But he says he sees the bigger picture
Frank Warren column: Amir Khan ready to meet winner of Floyd Mayweather v Manny Pacquiao

Khan ready to meet winner of Mayweather v Pacquiao

The Bolton fighter is unlikely to take on Kell Brook with two superstar opponents on the horizon, says Frank Warren
War with Isis: Iraq's government fights to win back Tikrit from militants - but then what?

Baghdad fights to win back Tikrit from Isis – but then what?

Patrick Cockburn reports from Kirkuk on a conflict which sectarianism has made intractable